trastuzumab vedotin (MRG002) / Lepu Med  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
trastuzumab vedotin (MRG002) / Lepu Med
NCT04941339: A Study of MRG002 in the Treatment of Patients With HER2-positive Advanced Solid Tumors

Recruiting
1
74
RoW
MRG002
Shanghai Miracogen Inc.
Advanced Solid Tumor
10/22
10/22

Download Options